Pharmafile Logo

Cyan Group

Cyan Group unites every stage of the communications lifecycle in a single solution so you can execute campaigns faster than ever before. We believe only through understanding the entire supply chain from creative through to delivery, can real consistency, control and effective communication be achieved. Giving you greater control to personalise your campaigns, tailoring the communications channel whilst significantly increasing your return on investment.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

5th Floor, Regal House, London Road, Twickenham, Middx, TW1 3QS, United Kingdom
+44 (0)20 88438600

 Latest Content from PMHub 

Wallace Health becomes an accredited PIF TICK member

Press Releases | February 16, 2024 | Wallace Health

PRESS RELEASE: Wallace Health gains PIF TICK accreditation to become a ‘trusted information creator’

6 content must-dos for 2024

Press Releases | February 16, 2024 | Wallace Health

What are the key trends and innovations that will shape the way we create health content in 2024?  Here are the six things the Wallace Health team will be focusing on...

5 ways to engage HCPs in medical education

White Papers and Resources | February 16, 2024 | Wiley

How to bring credibility, trust and flexibility into your medical education programs

Navigating challenges of MedTech research with rare-disease patients

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.

Did You Hear From Her? If Not Here’s What You Missed in Season 1 of the Award-Winning Season Podcast Series

What are some of the biggest gaps that women face in healthcare today?  “So many I could talk for hours!” said Shikha Jain, MD, FACP, President, CEO, Founder Women in Medicine....

Have you heard from her?

We’re referring to the renowned women leaders from across the healthcare landscape who were our guests on Season 1 of Medscape Education’s Hear From Her podcast series. The conversations touched...

Clinical trial considerations: Why diversity matters...

Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...

Rare disease market access – Launching orphan drugs in secondary markets: the Nordic and MENA regions

Press Releases | February 14, 2024 | Mtech Access

Join us live at 1.00pm (GMT)/2.00pm (CET)/8.00am (EST) on Thursday 29th February, to explore rare disease market access challenges and learn more about these high potential markets.

The pitfalls of cutting costs on systematic literature reviews: 11 common issues to avoid

Embarking on a systematic literature review is a critical step in evidence synthesis, providing a foundation for robust decision-making in the healthcare landscape. As with most things, there are ways...